These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34568038)

  • 1. Development and Validation of a
    Ouyang ML; Wang YR; Deng QS; Zhu YF; Zhao ZH; Wang L; Wang LX; Tang K
    Front Oncol; 2021; 11():710909. PubMed ID: 34568038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-[
    Xu L; Huang G; Wang Y; Huang G; Liu J; Chen R
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1729-1740. PubMed ID: 38150017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
    Huang Y; Jiang X; Xu H; Zhang D; Liu LN; Xia YX; Xu DK; Wu HJ; Cheng G; Shi YH
    Clin Radiol; 2023 Jan; 78(1):8-17. PubMed ID: 36192203
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
    Front Oncol; 2022; 12():911168. PubMed ID: 36003788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer.
    Ren C; Zhang F; Zhang J; Song S; Sun Y; Cheng J
    Eur J Med Res; 2023 Dec; 28(1):554. PubMed ID: 38042812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
    Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
    Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer.
    Xie Y; Zhao H; Guo Y; Meng F; Liu X; Zhang Y; Huai X; Wong Q; Fu Y; Zhang H
    Eur Radiol; 2021 Aug; 31(8):6030-6038. PubMed ID: 33560457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients.
    Li Q; Song Z; Zhang D; Li X; Liu Q; Yu J; Li Z; Zhang J; Ren X; Wen Y; Tang Z
    Front Oncol; 2022; 12():992906. PubMed ID: 36276058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An [
    Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
    Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
    Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
    PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 14. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
    Wang M; Liu L; Dai Q; Jin M; Huang G
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):247-261. PubMed ID: 36565319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
    Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
    BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prediction of lymph node metastasis in colorectal cancer using
    Wang Y; Zhao H; Fu P; Tian L; Su Y; Lyu Z; Gu W; Wang Y; Liu S; Wang X; Zheng H; Du J; Zhang R
    Med Phys; 2024 Aug; 51(8):5214-5225. PubMed ID: 38801340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
    Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
    Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer.
    Wumener X; Zhang Y; Wang Z; Zhang M; Zang Z; Huang B; Liu M; Huang S; Huang Y; Wang P; Liang Y; Sun T
    Front Oncol; 2022; 12():1005924. PubMed ID: 36439506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.